Jefferies Group Reiterates Buy on U.S. Physical Therap (USPH)

By admin | 6 years ago

U.S. Physical Therap (NASDAQ: USPH)‘s stock had its “buy” rating reiterated by equities research analysts at Jefferies Group (NYSE: JEF) in a research note issued to investors on Friday.

U.S. Physical Therap traded up 0.16% on Friday, hitting $25.10. U.S. Physical Therap has a 1-year low of $16.58 and a 1-year high of $26.23. The company has a market cap of $295.3 million and a price-to-earnings ratio of 13.77.

U.S. Physical Therap last released its earnings data on Thursday, May 3rd. The company reported $0.38 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.34 by $0.04. U.S. Physical Therap’s revenue was up 10.4% compared to the same quarter last year. On average, analysts predict that U.S. Physical Therap will post $0.39 earnings per share next quarter.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

About the author